Stable interval bone density in patients with eosinophilic oesophagitis on topical steroids

Authors:

Abstract
Objective This study was undertaken to evaluate the effects of maintenance topical steroids (TS) used for treatment in adult patients with eosinophilic esophagitis (EoE) on bone health. Patients and Methods We performed a retrospective review of patients with EoE (≥15 eosinophils/HPF on esophageal biopsy) who were seen in the Esophageal Clinic between January 1, 2013 and May 31, 2020, treated with maintenance TS for ≥one year and underwent bone health evaluation. Dual energy X‐ray absorptiometry (DEXA) scans were obtained during steroid induction therapy, with follow up studies obtained at least one year later. Demographic, laboratory, radiographic, endoscopic and histologic findings were reviewed. Results 21 patients had baseline and follow up DEXA scans (mean age of 44 years, slight male predominance (61.9%)). TS regimens included Budesonide‐Rincinol gel and Budesonide capsules mixed into slurry (induction dose range from 1.5 mg‐6 mg total daily, maintenance dose range from 0.5‐6 mg total daily). Mean follow up between initial and final DEXA was 707±391 days. Mean (±SD) baseline T‐score, Z‐score, and BMD (from spine, hips and femurs) (g/cm2) was ‐0.3±1.09, ‐0.06±0.93, and 1.05±0.15 respectively. Mean (±SD) change in bone mineral density was +0.38%±1.5% with mean change in absolute BMD of ‐0.01±0.04 g/cm2 (p=0.3). One patient progressed from normal BMD to osteopenia and none from osteopenia to osteoporosis. Conclusion Chronic maintenance steroid therapy in this pilot study does not appear to induce significant change in BMD in patients with EoE. Larger and longer trials are needed to validate these conclusions.

This publication has 36 references indexed in Scilit: